Prevtec Microbia has raised an undisclosed amount
Prevtec Microbia has raised an undisclosed amount.
Prevtec Microbia is a Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in food animals, improve animal health and increase animal production performance. It is an innovation-centric company that operates in many areas through strategic alliances around the world.
Oaklins’ team in Montreal, Canada, advised Prevtec Microbia in the transaction.
Contacter l'équipe de la transaction
Chef de la directionMontréal, Canada
Oaklins E. Canada
Bango plc growth capital for expansion
Bango plc has raised capital to finance its expansion plans.En apprendre plus
Narva clinics has been acquired by Narva Åderbråckscenter AB
The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.En apprendre plus
Bright Network has completed a fundraising
Bright Network has completed a fundraising to help support its continued growth.En apprendre plus